Drawing for SANKYO

USPTO serial 73573792

SANKYO

Reviewed by CopyMark Law Group

Reg. 1537858Status 710
Filing date
Status date
Registration date
May 9, 1989
Examiner
MANDIR, FREDERICK
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SANKYO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

FRIEDRICH KUEFFNER

FRIEDRICH KUEFFNER SIDLEY AUSTIN BROWN & WOOD LLP875 3RD AVE 24TH FLNEW YORK, NY 10022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001FOOD PRESERVATIVES; PLASTICIZERS, NAMELY, HIGH POLYMER STABILIZERS FOR PLASTICS AND PAINTS; ANTIOXIDANTS FOR USE IN DRINKS, CAKES, FLAVORING AGENTS, DAIRY PRODUCTS, FISH PASTE PRODUCTS; FOOD ADDITIVES; GERMINATION CONTROLLERS, NAMELY, GIBBERELLINS FOR GRAPES, ORANGES, CEDARS FOR CLOTTING TESTS, HORMONES FOR PLANTS, TETRODOTOXINS FOR USE AS RESEARCH REAGENTSSECTION 8 - CANCELLED—
005IN VITRO DIAGNOSTIC AGENTS FOR MEDICAL USE, DIAGNOSTIC AIDS FOR IN VITRO BIOLOGICAL TESTS, NAMELY, REAGENTS STRIPS FOR URINE AND BLOOD TESTS, CENTRAL NERVOUS SYSTEM DEPRESSANTS OPHTHALMIC USE AGENTS, ANTI-HISTAMINICS, CARDIOTONICS, ARRHYTHMIA TREATING AGENTS, DIURETICS, HYPOTENSORS, PROPHYLACTICS FOR THE TREATMENT OF ASTHMA, ANTITUSSIVES AND EXPECTORANTS, STOMACHICS AND DIGESTIVES, ANTACIDS, HORMONES, NAMELY, PITUITARY HORMONES FOR THE TREATMENT OF INFERTILITY, THYROID HORMONES FOR THE TREATMENT OF HYPERTHYROIDISM, ANABOLIC HORMONES FOR THE TREATMENT OF APLASTIC ANEMIA AND OSTEOPOROSIS, CORTICOSTEROIDS FOR TREATMENT OF HYPOPITUITARISM, CONGENITAL ADRENAL HYPERPLASIA, RHEUMATOID ARTHRITIS, RHEUMATIC FEVER, CROHN'S DISEASE, AND CHRONIC ACTIVE HEPATITIS, ESTROGEN AND PROGESTOGEN USED AS COMBINED ORAL CONTRACEPTIVES; URINARY ANTISEPTICS, ANALGESICS, ANTI-ITCHING AGENTS, CATAPLASMS FOR THE TREATMENT OF BRUISES, LUMBAGO, STIFFNESS AND FOR THE TREATMENT OF THE SHOULDER, HAIR REMEDIES, VITAMIN PREPARATIONS, FOOD ENRICHING AGENTS FOR TREATING VITAMIN DEFICIENCIES, ANTICOAGULANTS, ENZYME PREPARATIONS FOR CONTROL OF MALABSORPTION AND DIARRHEA, ANTI-CANCER PREPARATIONS, ANTI-SARCOMA PREPARATIONS, ANTIBIOTICS AND THEIR PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES, ANTITUBERCULOTIC AGENTS, INFLUENZA VACCINES, DIPHTHERIA VACCINES, TETANUS VACCINES, GAS GANGRENE VACCINES, JAPANESE ENCEPHALITIS VACCINES, ANTIPROTOZOALS FOR THE TREATMENT OF TRICHOMONIASIS AND DERMATOPHYTOSIS, ANTHELMINITICS FOR THE TREATMENT AGAINST THREADWORM AND FOR THE TREATMENT OF TOXOPLASMOSIS, EXCIPIENTS, NAMELY, TABLET COATING POLYMERS SOLUBLE IN THE GASTRIC TRACT, COLORING AGENTS FOR DISPENSING USE, NAMELY, B-CAROTENE, NATURALLY OCCURRING DRUGS AND CHARRED DRUGS AND MOXA FOR THE TREATMENT OF PEPTIC ULCERS, VETERINARY DRUGS FOR THE TREATMENT OF DISTEMPER IN DOGS, VETERINARY DRUGS FORTHE TREATMENT OF DISTOMATOSIS IN DOGS, VETERINARY DRUGS FOR THE TREATMENT OF COCCIDIUM IN CHICKENS, VETERINARY DRUGS FOR THE TREATMENT OF DYSENTERY IN PIGS, INSECTICIDES, RODENTICIDES, HERBICIDES, ANTISEPTICS, DRUGS FOR ARTERIOSCLEROSIS, ONCOSTATIC DRUGS FOR THE TREATMENT OF CANCER, MULTIENZYME DIGESTANTS, ANTIFUNGAL ANTIBIOTICS FOR THE TREATMENT OF TRICHOMONIASIS AND DERMATOPHYTOSIS, ANTIPARKINSONISM AGENTS, MINOR TRANQUILIZING AGENTS, AND ANTIANXIETY AGENTSSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 13, 1995C8..CANCELLED SEC. 8 (6-YR)—
May 9, 1989R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 10, 1989PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 1988NPUBNOTICE OF PUBLICATION—
Dec 10, 1988NPUBNOTICE OF PUBLICATION—
Jul 28, 1988CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 1988CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 13, 1988CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 9, 1987CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 1987CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 21, 1987CNSIINQUIRY AS TO SUSPENSION MAILED—
Apr 13, 1987CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 25, 1986CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 25, 1986CNSLLETTER OF SUSPENSION MAILED—
Jul 3, 1986CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 1986CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 1986DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance